ALZHEIMER’S RESEARCH: Scientists at drugmakers including Merck, Eli Lilly and Roche are starting a new round of studies of potential drugs to treat or perhaps even prevent Alzheimer’s disease.
HOPE ON HORIZON: The Alzheimer’s Association’s top scientist says if the studies pan out, a medicine to slow or even stop progression of the mind-robbing disease could be ready in three to five years.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.